European Science-Media Hub

European Science-Media Hub

Bringing scientists, journalists and policymakers together : communicate better sound science to all!

  • Home
  • COVID-19
    • COVID-19 interviews
    • COVID-19 vaccines
    • COVID-19 treatments
    • European responses
    • All COVID-19 articles
  • Infodemic
    • Fact checkers’ initiatives
    • Articles
    • Expert interviews
    • Reports
  • About ESMH
    • Team
    • Our mission
    • Our community
    • ESMH advisory board
  • Publications
    • Articles
    • Media review
    • Interviews
    • Videos
  • Events
    • Past Events
    • #eysmd2019
    • ESMH meets partners
  • Work with us
  • Subscribe
  • Home
  • COVID-19
    • COVID-19 interviews
    • COVID-19 vaccines
    • COVID-19 treatments
    • European responses
    • All COVID-19 articles
  • Infodemic
    • Fact checkers’ initiatives
    • Articles
    • Expert interviews
    • Reports
  • About ESMH
    • Team
    • Our mission
    • Our community
    • ESMH advisory board
  • Publications
    • Articles
    • Media review
    • Interviews
    • Videos
  • Events
    • Past Events
    • #eysmd2019
    • ESMH meets partners
  • Work with us
  • Subscribe

EU Project : CLARIFY

on November 20, 2019

EU project Clarify ESMH
EU project Clarify

CLARIFY : There were 17 million new cases of cancer diagnosed worldwide in 2018. Survival rates of cancer patients were rather poor until recent decades, when diagnostic techniques have been improved and novel therapeutic options have been developed. It is estimated that more than 50% of adult patients diagnosed with cancer live at least 5 years in the US and Europe. This situation leads to a new challenge: to increase the cancer patients’ post-treatment quality of life and well-being. This proposal aims at identifying cancer survivors from three prevalent types of cancer, including breast, lung and lymphomas. The patient data will be collected from different Spanish hospitals and the selection will be based on ongoing health and supportive care needs of the particular patient types. We will determine the personalised factors that predict poor health status after specific oncological treatments. For this aim, Big Data and Artificial Intelligence techniques will be used to integrate all available patient´s information with publicly available relevant biomedical databases as well as information from wearable devices used after the treatment. To predict patient-specific risk of developing secondary effects and toxicities of their cancer treatments, we will build novel models based on statistical relational learning and explainable AI techniques on top of the integrated knowledge graphs. The models will utilise background knowledge of the associated cancer biology and thus will help clinicians to make evidence-based post-treatment decisions in a way that is not possible at all with any existing approach. In summary, CLARIFY proposes to integrate and analyse large volumes of heterogenous multivariate data to facilitate early discovery of risk factors that may deteriorate a patient condition after the end of oncological treatment. This will effectively help to stratify cancer survivors by risk in order to personalize their follow-up by better assessment of their needs.

Coordination : SERVICIO MADRILENO DE SALUD

Funding Scheme : RIA – Research and Innovation action

Web-link : https://cordis.europa.eu/project/rcn/225740/factsheet/en

  • Category: EU projects
  • Tags: artificial intelligence, cancer, health
  • Share this:

    • Click to share on Twitter (Opens in new window)
    • Click to share on Facebook (Opens in new window)
    • Click to share on Pinterest (Opens in new window)
    • Click to share on LinkedIn (Opens in new window)
    • Click to share on WhatsApp (Opens in new window)

Leave a Reply Cancel reply

Subscribe to the ESMH content
Digital Humanities Series banner
sidebar covid-19
ESMH Call for expression of interest
ESMH Press Review

Follow Us

  • Twitter
  • Facebook
  • LinkedIn
  • YouTube
  • Instagram
  • Flickr
  • Reddit
  • Pinterest

Most Popular / last 48 h

  • The differences between SARS-CoV-1 and SARS-CoV-2
    The differences between SARS-CoV-1 and SARS-CoV-2
  • Bean there, done that : why we should eat more beans and legumes in general
    Bean there, done that : why we should eat more beans and legumes in general
  • Covid-19: different types of vaccines and how they work
    Covid-19: different types of vaccines and how they work
  • ESMH selection: sources of information about Coronavirus
    ESMH selection: sources of information about Coronavirus
  • A scientist’s opinion : Interview with Linda Amaral-Zettler about plastic pollution
    A scientist’s opinion : Interview with Linda Amaral-Zettler about plastic pollution

Archives

Categories

  • Articles (99)
    • Artificial Intelligence (11)
    • Communication (11)
    • Disinformation (20)
    • Environment (8)
    • Food (3)
    • Health (45)
    • Industry (2)
    • Information Society (4)
    • New Technologies (8)
    • Policy (6)
    • Research (5)
    • Robotics (2)
    • Security (1)
    • Social Sciences (7)
    • Society (5)
    • Transport (1)
  • ESMH meets partners (4)
  • EU projects (51)
  • Interviews (138)
  • Media review (43)
  • Other (12)
  • Outcomes (5)
  • Past Events (10)
  • STOA studies (5)
  • Videos (7)
Article RSS
Comment RSS
Disclaimer & Copyright
Terms & Conditions
EPRS blog
STOA website

Follow Us

  • Twitter
  • Facebook
  • LinkedIn
  • YouTube
  • Instagram
  • Flickr
  • Reddit
  • Pinterest
Copyright © European Union, 2018. All rights reserved.